RUSSELL PULLEN: Open Payments
NPI 1558381129 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 25 payments from 6 companies in 2025. Trend: 2023 $175 · 2024 $417 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $241 |
| GlaxoSmithKline, LLC. | 10 | $150 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Optinose US, Inc. | 1 | $27 |
| Phadia US Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, ImmunoCAP, Ryaltris.
Industry payments across TN — which companies pay providers there.
